CAPTRUST Financial Advisors Portfolio holdings
AUM $44.8B
1-Year Return
16.03%
This Quarter Return
-0.88%
1 Year Return
+16.03%
3 Year Return
+60.22%
5 Year Return
+112.11%
10 Year Return
+201.46%
AUM
$39.9B
AUM Growth
+$4.85B
(+14%)
Cap. Flow
+$5.57B
Cap. Flow
% of AUM
13.98%
Top 10 Holdings %
Top 10 Hldgs %
25.25%
Holding
2,479
New
188
Increased
1,256
Reduced
810
Closed
128
Top Buys
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$343M |
| 2 |
Apple
AAPL
|
+$211M |
| 3 |
Watsco
WSO
|
+$171M |
| 4 |
Microsoft
MSFT
|
+$168M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$164M |
Top Sells
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$65M |
| 2 |
Nucor
NUE
|
+$62.9M |
| 3 |
Oracle
ORCL
|
+$58M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Tesla
TSLA
|
+$38.2M |
Sector Composition
| 1 | Technology | 13.09% |
| 2 | Financials | 8.18% |
| 3 | Healthcare | 5.47% |
| 4 | Industrials | 4.85% |
| 5 | Consumer Discretionary | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Cipher Mining
CIFR
$4.53B
| $33.8K | ﹤0.01% |
14,678
+2,942
| +25% | +$6.77K |
|
2302
AmeriServ Financial
ASRV
$50.2M
| $32.8K | ﹤0.01% |
13,483
| – | – |
|
2303
ImmunityBio
IBRX
$2.66B
| $32.3K | ﹤0.01% |
+10,741
| New | +$32.3K |
|
2304
NET Power
NPWR
$171M
| $30.1K | ﹤0.01% |
+11,431
| New | +$30.1K |
|
2305
Imperial Petroleum
IMPP
$160M
| $30.1K | ﹤0.01% |
12,270
+1,010
| +9% | +$2.48K |
|
2306
Digital Turbine
APPS
$579M
| $29.7K | ﹤0.01% |
+10,932
| New | +$29.7K |
|
|
IRD
2307
Opus Genetics, Inc. Common Stock
IRD
$83.9M
| $27.5K | ﹤0.01% |
28,000
| – | – |
|
2308
Hyliion Holdings
HYLN
$319M
| $27.4K | ﹤0.01% |
19,552
-332
| -2% | -$465 |
|
2309
C4 Therapeutics
CCCC
$243M
| $26.2K | ﹤0.01% |
16,402
+2,073
| +14% | +$3.32K |
|
2310
Arbe Robotics
ARBE
$154M
| $25.8K | ﹤0.01% |
+25,048
| New | +$25.8K |
|
2311
Zentalis Pharmaceuticals
ZNTL
$102M
| $25.4K | ﹤0.01% |
15,945
+5,162
| +48% | +$8.21K |
|
2312
Geron
GERN
$798M
| $24.5K | ﹤0.01% |
15,405
+1,161
| +8% | +$1.85K |
|
2313
Bridger Aerospace
BAER
$101M
| $23.2K | ﹤0.01% |
+20,529
| New | +$23.2K |
|
2314
Cerus
CERS
$242M
| $22.8K | ﹤0.01% |
+16,400
| New | +$22.8K |
|
|
HIVE
2315
HIVE Digital Technologies
HIVE
$891M
| $22.2K | ﹤0.01% |
15,278
-350
| -2% | -$507 |
|
2316
Nektar Therapeutics
NKTR
$949M
| $21.9K | ﹤0.01% |
2,143
+1,343
| +168% | +$13.7K |
|
2317
8x8 Inc
EGHT
$275M
| $20.6K | ﹤0.01% |
10,321
-932
| -8% | -$1.86K |
|
2318
iHeartMedia
IHRT
$446M
| $20.3K | ﹤0.01% |
+12,327
| New | +$20.3K |
|
2319
Dyadic International
DYAI
$35.9M
| $20.3K | ﹤0.01% |
15,000
| – | – |
|
2320
Sangamo Therapeutics
SGMO
$155M
| $19.2K | ﹤0.01% |
29,255
| – | – |
|
2321
Armata Pharmaceuticals
ARMP
$104M
| $19.2K | ﹤0.01% |
13,140
| – | – |
|
2322
Sana Biotechnology
SANA
$797M
| $18.5K | ﹤0.01% |
+10,986
| New | +$18.5K |
|
2323
Tiziana Life Sciences
TLSA
$195M
| $18.4K | ﹤0.01% |
17,000
| – | – |
|
|
ADAP
2324
Adaptimmune Therapeutics
ADAP
$21.7M
| $15.9K | ﹤0.01% |
80,609
-1,020
| -1% | -$201 |
|
|
CANF
2325
Can-Fite BioPharma
CANF
$10.2M
| $15.7K | ﹤0.01% |
+10,634
| New | +$15.7K |
|